Turkey walks an economic tightrope

The Turkish central bank is in a bind over whether or not to raise interest rates.

Spare a thought for Erdem Basci, Turkey's central-bank governor, says Edward Hadas on breakingviews.com. He is walking a tightrope in his efforts to support both the country's currency, the lira, which is now at record lows against the dollar, and the economy.

Sputtering growth argues for an immediate interest-rate cut, but rising inflation and the ongoing need to attract foreign capital to fund the country's current-account deficit demand just the opposite.

To make matters worse, Basci is being berated by Recep Tayyip Erdogan, Turkey's increasingly autocratic and eccentric president, for falling under the influence of a foreign "interest-rate lobby", continues Hadas. Erdogan believes that this lobby is making Basci keep rates high and he "seemingly does not understand how much Turkey needs foreign confidence".

Erdogan, who appears to think that high interest rates cause inflation, rather than vice versa, may have to learn the hard way, says Daniel Dombey in the FT. Foreign investors could rush out, sending the currency crashing, inflation rocketing, and requiring even higher interest rates to win back foreign confidence.It all adds up to another headache for emerging-market investors.

Recommended

How the Covid-19 vaccine crisis is putting the EU in danger
EU Economy

How the Covid-19 vaccine crisis is putting the EU in danger

The botched coronavirus vaccine campaign will cause long-term harm to the EU's economy, says Matthew Lynn.
4 Apr 2021
How the vaccine wars will harm us all
Global Economy

How the vaccine wars will harm us all

Grabbing and hoarding vaccine supplies, or even manufacturing one’s own, might seem to make sense for a state in an emergency. But the damage done to …
27 Mar 2021
The European Central Bank fumbles its way towards yield curve control
EU Economy

The European Central Bank fumbles its way towards yield curve control

The EU’s economic recovery is faltering, but its bond yields keep rising. That makes things tricky for the European Central Bank, says John Stepek. He…
12 Mar 2021
Vexing vaccine delays hit drug firms
Biotech stocks

Vexing vaccine delays hit drug firms

AstraZeneca and Pfizer are being attacked by the EU over what it claims are delays in delivering the Covid vaccine.
28 Jan 2021

Most Popular

Central banks are rushing to build digital currencies. What are they, and what do they mean for you?
Bitcoin

Central banks are rushing to build digital currencies. What are they, and what do they mean for you?

As bitcoin continues to soar in value, many of the world’s central banks are looking to emulate it by issuing their own digital currencies. But centra…
8 Apr 2021
House prices: from boom to even bigger boom
House prices

House prices: from boom to even bigger boom

UK house prices have risen to new to record highs, says Nicole Garcia Merida. Demand continues to outpace supply, but continued low interest rates, th…
9 Apr 2021
Nuclear power might never be popular – but now looks a good time to invest
Commodities

Nuclear power might never be popular – but now looks a good time to invest

Nuclear power gets a very bad press, but it is the ultimate renewable energy source. Interest in it is perking up again, says John Stepek. Which means…
9 Apr 2021